View in EDS HTML Full Text PDF Full Text

'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.

Saved in:
Bibliographic Details
Title: 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
Authors: Vissing J; Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark. john.vissing@regionh.dk., Jacob S; Queen Elizabeth Neuroscience Centre and Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK., Fujita KP; Alnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, MA, 02142, USA.; Formerly Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA., O'Brien F; Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA., Howard JF; Department of Neurology, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599-7025, USA.
Corporate Authors: REGAIN study group
Source: Journal of neurology [J Neurol] 2020 Jul; Vol. 267 (7), pp. 1991-2001. Date of Electronic Publication: 2020 Mar 18.
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1459 (Electronic) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32189108
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vissing+J%22">Vissing J</searchLink>; Department of Neurology, Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark. john.vissing@regionh.dk.<br /><searchLink fieldCode="AU" term="%22Jacob+S%22">Jacob S</searchLink>; Queen Elizabeth Neuroscience Centre and Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Edgbaston, Birmingham, B15 2WB, UK.<br /><searchLink fieldCode="AU" term="%22Fujita+KP%22">Fujita KP</searchLink>; Alnylam Pharmaceuticals, 675 West Kendall Street, Cambridge, MA, 02142, USA.; Formerly Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA.<br /><searchLink fieldCode="AU" term="%22O'Brien+F%22">O'Brien F</searchLink>; Alexion Pharmaceuticals, 121 Seaport Boulevard, Boston, MA, 02210, USA.<br /><searchLink fieldCode="AU" term="%22Howard+JF%22">Howard JF</searchLink>; Department of Neurology, University of North Carolina, 170 Manning Drive, Chapel Hill, NC, 27599-7025, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22REGAIN+study+group%22">REGAIN study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220423161%22">Journal of neurology</searchLink> [J Neurol] 2020 Jul; Vol. 267 (7), pp. 1991-2001. <i>Date of Electronic Publication: </i>2020 Mar 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag%22">Springer-Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>0423161 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-1459 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203405354%22">03405354 </searchLink><i>NLM ISO Abbreviation: </i>J Neurol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32189108
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00415-020-09770-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1991
    Titles:
      – TitleFull: 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vissing J
      – PersonEntity:
          Name:
            NameFull: Jacob S
      – PersonEntity:
          Name:
            NameFull: Fujita KP
      – PersonEntity:
          Name:
            NameFull: O'Brien F
      – PersonEntity:
          Name:
            NameFull: Howard JF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2020 Jul
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1432-1459
          Numbering:
            – Type: volume
              Value: 267
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal of neurology
              Type: main
ResultId 1